Trial Profile

Phase II trial of ALX 0141 in patients with bone metastases.

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 27 May 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs ALX 0141 (Primary)
Indications Bone metastases; Cancer
Focus Therapeutic Use
Sponsors Ablynx

Most Recent Events

25 May 2011 This trial is expected to start by the end of 2011, according to an Ablynx media release.
23 Sep 2010 New trial record
20 Sep 2010 This trial is expected to commence in the second half of 2011, according to an Ablynx media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com